Approval of Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June 2026 and other items .
07-Aug-2026
Download PDF
Vivanza Bioscience
Approval of Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June 2026 and other items .